EA202191335A1 - COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY - Google Patents

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Info

Publication number
EA202191335A1
EA202191335A1 EA202191335A EA202191335A EA202191335A1 EA 202191335 A1 EA202191335 A1 EA 202191335A1 EA 202191335 A EA202191335 A EA 202191335A EA 202191335 A EA202191335 A EA 202191335A EA 202191335 A1 EA202191335 A1 EA 202191335A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
compositions
treatment
conditions associated
nlrp
Prior art date
Application number
EA202191335A
Other languages
Russian (ru)
Inventor
Шомир Гхош
Гари Глик
Джейсон Катц
Уилльям Рауш
Ханс Мартин Зайдель
Дун-Мин Шэнь
Шанкар Венкатраман
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Priority claimed from PCT/US2019/060770 external-priority patent/WO2020102096A1/en
Publication of EA202191335A1 publication Critical patent/EA202191335A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В одном аспекте представлены соединения формулы (AA) или их фармацевтически приемлемые солиили их фармацевтически приемлемые соли, где переменные, показанные в формуле (A), могут быть такими, как определено в любом месте в данном документе.In one aspect, compounds of formula (AA) are provided, or pharmaceutically acceptable salts thereof, or pharmaceutically acceptable salts thereof, wherein the variables shown in formula (A) may be as defined elsewhere herein.

EA202191335A 2019-09-04 2019-11-11 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY EA202191335A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895595P 2019-09-04 2019-09-04
PCT/US2019/060770 WO2020102096A1 (en) 2018-11-13 2019-11-11 Compounds and compositions for treating conditions associated with nlrp activity

Publications (1)

Publication Number Publication Date
EA202191335A1 true EA202191335A1 (en) 2021-12-10

Family

ID=80631165

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191335A EA202191335A1 (en) 2019-09-04 2019-11-11 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Country Status (1)

Country Link
EA (1) EA202191335A1 (en)

Similar Documents

Publication Publication Date Title
CL2020000215A1 (en) Compounds and compositions for treating conditions associated with nlrp activity.
MX2021005529A (en) Compounds and compositions for treating conditions associated with nlrp activity.
CU20210065A7 (en) 3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOLE COMPOUNDS THAT HAVE INHIBITORY ACTIVITY ON CDK2
MD3319611T2 (en) Oxysterols and methods of use thereof
MD3319612T2 (en) Oxysterols and methods of use thereof
MX2022012317A (en) Oxysterols and methods of use thereof.
EA201690669A1 (en) SUBSTITUTED DERIVATIVES OF QUINOLYSIN THAT CAN BE USED AS AN HIV INTEGRASE INHIBITORS
MX2017014613A (en) Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase.
EA201791955A1 (en) TGF-β INHIBITORS
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
EA201591457A8 (en) THERAPEUTIC CONNECTIONS
EA202191519A1 (en) TREX1 MODULATORS
EA201991349A1 (en) TETRACYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS HIV INTEGRAS INHIBITORS
MX2018008095A (en) Fused tricyclic heterocyclic compounds as hiv integrase inhibitors.
EA202092748A1 (en) APOL1 EXPRESSION MODULATORS
EA201890862A1 (en) HUMAN PLASMA CALICIREIN INHIBITORS
PH12021550304A1 (en) Novel medicament for treating inflammatory bowel disease
MX2021012105A (en) Pyrrole compounds.
WO2019094552A8 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
WO2020154499A8 (en) Sulfonimidamide compounds and compositions for treating conditions associated with nlrp activity
EA201700356A1 (en) NEW CYCLOPROPANBENZOFURANILPYRIDOPYRAZINDIONS
EA202191335A1 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
EA202191966A1 (en) PENTACYCLIC HETEROCYCLIC COMPOUND
WO2020096916A3 (en) Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection
DOP2021000090A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP